Panome Bio Receives CLIA Certification, Elevating Clinical Laboratory Standards

Enhancing Clinical Standards: Panome Bio Achieves CLIA Certification

Panome Bio, renowned for its groundbreaking technologies in proteomic, metabolomic, and transcriptional profiling, has proudly announced its achievement of Clinical Laboratory Improvement Amendments (CLIA) certification for its cutting-edge laboratory. This important milestone underscores the company’s dedication to providing the highest quality in clinical laboratory testing, ensuring accuracy, reliability, and excellence throughout its operations.

The CLIA certification is crucial for researchers involved in clinical trials as it demands rigorous quality control, thorough documentation, and precise regulatory reporting. This designation indicates that Panome Bio's services meet stringent standards for precision in handling patient samples and developing clinical laboratory tests. With this certification, the entire process at Panome Bio, from sample intake to data communication, adheres to or surpasses the requirements set for critical and sensitive projects.

Adam Richardson, Vice President of Operations at Panome Bio, expressed pride in this accomplishment, stating, "Panome Bio has always prioritized scientific and operational excellence, and we are proud to now have a formal certification of our capabilities. This CLIA certification is the result of our entire team's commitment to accuracy and reliability, enabling Panome Bio to bring our analytical excellence to clinical trials and other regulated programs."

The laboratory features state-of-the-art mass spectrometry technology for metabolomics and proteomics, alongside transcription profiling and comprehensive bioinformatics capabilities. This combination ensures the utmost precision and throughput, aligning with the highest standards required in the clinical research landscape. With the CLIA certification, Panome Bio can expand its innovative multi-omic services to a wider array of clinical partners, including pharmaceutical companies, academic research institutions, and healthcare providers, thereby enhancing the landscape of clinical research.

About Panome Bio

Panome Bio operates as a contract research organization, specializing in metabolomics, proteomics, transcriptomics, and integrated multi-omics data analysis. The company supports clients in their endeavors to advance research in disease understanding and drug development. Offering a complete workflow that encompasses experimental design, sample collection and processing, data analysis, and reporting, Panome Bio positions itself as a leader in the clinical laboratory service field.

For further details about their services or inquiries, visit their website or connect with them on LinkedIn.

Conclusion

The achievement of CLIA certification marks a significant step for Panome Bio, enhancing its credibility and capability in an ever-demanding clinical environment. As they continue to innovate and provide essential services for research and healthcare advancements, Panome Bio stands out as a leader committed to supporting the scientific community effectively. The journey towards improved patient care and breakthrough discoveries remains at the forefront of their mission.